ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 697685 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 697685; 2) Community: the network communities that were significantly associated with the response to NSC 697685; 3) Molecule: the relationships between components within communities and NSC 697685; 4) MDR: the compounds that were significantly associated with the NSC 697685.

NSC Compound Enrichment Correlation
NSC 683558 Camptothecin Derivative 0.000573863872925591 0.6890866
NSC 720529 N-(6'-Chrysenyl)-4-(1'-piperidinyl)-D-2,3-dioxalono-butane-1 ,4-dicarboximide 0.000573863872925603 0.51406973
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.000573863872925603 0.49541168
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.000588249147782798 0.36255112
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.000588249147782798 0.75641187
NSC 287459 Cytarabine AY 0.000588249147782811 0.55844423
NSC 680350 Null 0.000588249147782811 0.19943186
NSC 624851 Null 0.000649370174092101 0.63890692
NSC 638436 Null 0.000649370174092101 0.57123977
NSC 642328 Benzonitrile, 4-[[1,3,3a,4,9,9a-hexahydro-9-(4-hydroxy- 3,5-dimethoxyphenyl)-6,7-dimethoxy- 1-oxonaphtho[2,3-c]furan-4-yl]amino]-, [3aS-(3a.alpha.,4.beta.,9.alpha.,9a.beta.)]- (9CI) 0.000649370174092101 0.65397097
Total:94  Current:3    [First] [Prev] [Next] [Last]